BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Biovest International, Inc. Conducts End of Phase III Review With FDA of BiovaxID™ as Consolidation Therapy in Non-Hodgkin’s Lymphoma

  August 14, 2012

   · 

  1 min read
• Pharm Country

  JARVIK HEART, Inc. Announces Full FDA Approval of the Jarvik 2000 Destination Therapy Trial

  August 14, 2012

   · 

  3 min read
• Business

  ERBA Diagnostics, Inc. Reports Second Quarter 2012 Financial Results

  August 14, 2012

   · 

  1 min read
• Biotech Bay

  ClinStar to Co-Host Roundtable Discussion on Optimizing Site Selection in Emerging Markets for Global Clinical Trials

  August 14, 2012

   · 

  1 min read
• Business

  Array BioPharma, Inc. Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012

  August 14, 2012

   · 

  1 min read
• Allergists Available to All at Aerius(R) Allergy Clinic in Montreal and Laval Shopping Malls - Merck & Co., Inc.

  August 14, 2012

   · 

  1 min read
• Pharm Country

  Chembio Diagnostics, Inc. Launches New Company Web Site

  August 14, 2012

   · 

  1 min read
• Policy

  Santarus Inc. Announces FDA Extension of UCERIS New Drug Application Target Action Date to January 16, 2013

  August 14, 2012

   · 

  1 min read
• BioMidwest

  New Study From St. Elizabeth Health Center Trauma Team Demonstrates Value of Cheetah Medical Inc.'s NICOM® Bioreactance® Technology in Level I Trauma Center

  August 14, 2012

   · 

  4 min read
• Business

  Axis Diagnostics and Advanced Data Systems Collaborate on EHR and Lab

  August 14, 2012

   · 

  3 min read